News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Stephen Liu: Molecular Determinants of Efficacy with Sotorasib in KRASG12C NSCLC by Ferdinandos Skoulidis et al.
Collage photo of Stephen Liu and Ferdinandos Skoulidis
May 29, 2025, 17:09

Stephen Liu: Molecular Determinants of Efficacy with Sotorasib in KRASG12C NSCLC by Ferdinandos Skoulidis et al.

Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics, and Associate Professor at the Georgetown Lombardi Comprehensive Cancer Center, shared a post on X about a paper by Ferdinandos Skoulidis et al. published in Nature Medicine:

“Report in Nature Medicine from Ferdinandos Skoulidis on molecular determinants of efficacy with sotorasib in KRAS G12C NSCLC. TTF1 expression, NRF2 activation, and KEAP1 and ATM mutations were relevant. Can ctDNA clearance be used as an early pharmacodynamic marker?

Title: Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer

Authors: Ferdinandos Skoulidis, Bob T. Li, Adrianus Johannes de Langen, David S. Hong, Herve Lena, Juergen Wolf, Grace K. Dy, Alessandra Curioni Fontecedro, Pascale Tomasini, Vamsidhar Velcheti, Anthonie J. van der Wekken, Christophe Dooms, Luis Paz-Ares Rodriguez, Giannis Mountzios, Adrian Sacher, Ernest Nadal, Sebastien Couraud, Sang-We Kim, Kenneth O’Byrne, Danilo Rocco, Ryo Toyozawa, Izabela Chmielewska, Colin R. Lindsay, Antreas Hindoyan, Lata Mukundan, Tomasz Wilmanski, Abraham Anderson, Christine Ardito-Abraham, Amrita Pati, Anita Reddy, Bhakti Mehta, Martin Schuler

Stephen Liu: Molecular Determinants of Efficacy with Sotorasib in KRASG12C NSCLC by Ferdinandos Skoulidis et al.

You can read the Full Article in Nature Medicine.

Read the post on “New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer” in OncoDaily.

More posts featuring Stephen V Liu.

Abraham Anderson Adrianus Johannes de Langen Amrita Pati Anita Reddy Bhakti Mehta Bob T. Li cancer Christine Ardito-Abraham David S. Hong Ferdinandos Skoulidis Herve Lena KRAS G12C Lung cancer Martin Schuler NSCLC OncoDaily Oncology Sotorasib Stephen V Liu TTF1
Special Coverage
Science
May 29, 2025, 17:09
Stephen Liu: Molecular Determinants of Efficacy with Sotorasib in KRASG12C NSCLC by Ferdinandos Skoulidis et al.
Career
May 29, 2025, 16:54
Paulo Bergerot: Proud and Grateful for 2024 Reviewer Recognition from JCO Global Oncology
Blog
May 29, 2025, 16:50
Shubh Goel: Discover AstraZeneca’s Vision for Cancer Care at ASCO 2025
Blog
May 29, 2025, 16:37
Children’s Cancer Institute Shares Jack’s Journey Through Brain Cancer and Clinical Trial Success
Science
May 29, 2025, 16:36
Beliz Bahar Karaoğlan: Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis
Blog
May 29, 2025, 16:26
Porscha Johnson: Two More Days Before Our Live Interactive Molecular Tumor Board at ASCO 2025
Blog
May 29, 2025, 16:16
From Targeted Therapies to Early Detection, Connect With SCRI at ASCO25 - Sarah Cannon Research Institute
Blog
May 29, 2025, 15:41
Meet The Translational and Therapeutic Research in Pancreatic Cancer Team at Cancer Research Centre of Marseille - AFRCP
Career
May 29, 2025, 15:32
Join University of Arizona Cancer Center at ASCO 2025 to Explore Oncology Job Opportunities
Blog
May 29, 2025, 15:10
FORwards Special Interest Group Webinar on Fear of Cancer Recurrence Featuring Expert Christine Maheu
Blog
May 29, 2025, 14:19
Anna Cabanes on ATOM Coalition's Milestone in Global Cancer Access Program at the Recent Workshop in Zambia
Insight
May 29, 2025, 14:15
New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer